Email: Opioid talks fail, Purdue bankruptcy filing expected
OxyContin maker Purdue Pharma is expected to file for bankruptcy after settlement talks over the nation’s deadly overdose crisis hit […]
Over the course of a decade, out-of-pocket costs for multiple sclerosis drugs rose more than sevenfold for Medicare Part D […] To combat the rise of drug-resistant bacteria, researchers are examining how one superbug adapts to fight an antibiotic of last […] Treating cancer more selectively and more effectively—this could be achieved with an innovative technology developed by teams of researchers at […] A new study led by the Neuropharmacology Laboratory (NeuroPhar) at UPF shows that increasing endocannabinoids in the brain may cause […] (HealthDay)—Since 2008, there has been a decrease in opioid prescribing and new persistent use after vaginal or cesarean delivery, according […] Two experimental Ebola treatments being used in the current outbreak in eastern Democratic Republic of the Congo have proved effective […] (HealthDay)—For patients with atrial fibrillation (AF), the efficacy and safety of edoxaban versus warfarin is not altered with a history […] Opioids work against severe pain but the risks of side effects and addiction are high. In the U.S. alone, 26 […] A targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced […]Medications
Medicare patients with multiple sclerosis bear the burden of rising drug prices
In search of clues to fight antibiotic resistance
Bringing cancer medication safely to its destination
A paradoxical proinflammatory effect of endocannabinoids in the brain discovered
Opioid prescribing, new persistent use down after childbirth
Lab tests show experimental Ebola treatments effective
History of liver disease does not impact efficacy of edoxaban
High rates of opioid prescriptions for osteoarthritis
One lung cancer drug receives NHS England approval, while another is rejected